» Authors » Ramon Lobato-Busto

Ramon Lobato-Busto

Explore the profile of Ramon Lobato-Busto including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 176
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez-Pleguezuelos C, Aguado-Barrera M, Carballo-Castro A, Peleteiro P, Calvo-Crespo P, Taboada-Valladares B, et al.
Clin Epigenetics . 2025 Mar; 17(1):43. PMID: 40050897
Background: Prostate cancer is the second most common cancer globally, with radiation therapy (RT) being a key treatment for clinically localized and locally advanced cases. Given high survival rates, addressing...
2.
Naderi E, Aguado-Barrera M, Schack L, Dorling L, Rattay T, Fachal L, et al.
JNCI Cancer Spectr . 2023 Oct; 7(6). PMID: 37862240
Background: This study was designed to identify common genetic susceptibility and shared genetic variants associated with acute radiation-induced toxicity across 4 cancer types (prostate, head and neck, breast, and lung)....
3.
Naderi E, Schack L, Welsh C, Sim A, Aguado-Barrera M, Dudding T, et al.
Radiother Oncol . 2022 Oct; 176:138-148. PMID: 36191651
Background And Purpose: We aimed to the genetic components and susceptibility variants associated with acute radiation-induced toxicities (RITs) in patients with head and neck cancer (HNC). Materials And Methods: We...
4.
Webb A, Harper E, Rattay T, Aguado-Barrera M, Azria D, Bourgier C, et al.
EBioMedicine . 2022 Sep; 84:104269. PMID: 36130474
Background: Circadian rhythm impacts broad biological processes, including response to cancer treatment. Evidence conflicts on whether treatment time affects risk of radiotherapy side-effects, likely because of differing time analyses and...
5.
Aguado-Barrera M, Martinez-Calvo L, Fernandez-Tajes J, Calvo-Crespo P, Taboada-Valladares B, Lobato-Busto R, et al.
Cancers (Basel) . 2021 Apr; 13(6). PMID: 33810047
Several studies have identified single-nucleotide polymorphisms (SNPs) associated with adverse effects in non-small-cell lung cancer (NSCLC) patients treated with radiation therapy. Here, using an independent cohort, we aimed to validate...
6.
Seibold P, Webb A, Aguado-Barrera M, Azria D, Bourgier C, Brengues M, et al.
Radiother Oncol . 2019 May; 138:59-67. PMID: 31146072
Purpose: REQUITE aimed to establish a resource for multi-national validation of models and biomarkers that predict risk of late toxicity following radiotherapy. The purpose of this article is to provide...
7.
Kerns S, Fachal L, Dorling L, Barnett G, Baran A, Peterson D, et al.
J Natl Cancer Inst . 2019 May; 112(2):179-190. PMID: 31095341
Background: A total of 10%-20% of patients develop long-term toxicity following radiotherapy for prostate cancer. Identification of common genetic variants associated with susceptibility to radiotoxicity might improve risk prediction and...
8.
Fachal L, Gomez-Caamano A, Barnett G, Peleteiro P, Carballo A, Calvo-Crespo P, et al.
Nat Genet . 2014 Jul; 46(8):891-4. PMID: 24974847
There is increasing evidence supporting the role of genetic variants in the development of radiation-induced toxicity. However, previous candidate gene association studies failed to elucidate the common genetic variation underlying...
9.
Fachal L, Mosquera-Miguel A, Gomez-Caamano A, Sanchez-Garcia M, Calvo P, Lobato-Busto R, et al.
Radiother Oncol . 2014 Apr; 111(2):199-205. PMID: 24746576
Background And Purpose: Mitochondrial DNA common variants have been reported to be associated with the development of radiation-induced toxicity. Using a large cohort of patients, we aimed to validate these...
10.
Fachal L, Gomez-Caamano A, Peleteiro P, Carballo A, Calvo-Crespo P, Sanchez-Garcia M, et al.
Radiother Oncol . 2012 Oct; 105(3):321-8. PMID: 23075580
Background And Purpose: We have performed a case-control study among prostate cancer patients treated with three-dimensional conformational radiotherapy (3D-CRT) in order to investigate the association between single nucleotide polymorphisms (SNPs),...